1. Paper › Research › Not peer-reviewed
2. Published

   Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.

   Hughes, D., Hughes, D. A., Bodger, K. & Kikuchi, T., 1 Apr 2008.

   Research output: Contribution to conference › Paper

3. Published

   Cost-effectiveness considerations in pharmacogenetics.

   Hughes, D. & Hughes, D. A., 1 Jan 2008.

   Research output: Contribution to conference › Paper

4. Published

   Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease

   Hughes, D. & Hughes, D. A., 1 Nov 2003.

   Research output: Contribution to conference › Paper

5. Published

   Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease

   Hughes, D. & Hughes, D. A., 1 Nov 2003.

   Research output: Contribution to conference › Paper

6. Published

   Costs of non-compliance to antipsychotic medications among patients with schizophrenia.

   Hughes, D., Hughes, D. A., Salas, M., Zuluaga, A., Cowell, W., Lebmeier, M., Vardeva, K., Pisu, M. & Shinogle, J., 1 May 2008.

   Research output: Contribution to conference › Paper

7. Published

   Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?

   Hughes, D., Hughes, D. A., Pirmohamed, M. & Bayoumi, A., 1 Aug 2007.

   Research output: Contribution to conference › Paper

8. Published

   Dementia and Imagination

   Windle, G., 4 Jun 2014.

   Research output: Contribution to conference › Paper

9. Published

   Developing a SOP for costing health, social care and drugs in economic evaluation alongside randomised trials: Issues for discussion.

   Edwards, R. T. & Yeo, S. T., 1 Jan 2008.

   Research output: Contribution to conference › Paper

10. Published

    Developing a visual arts intervention

    Windle, G., 1 Sept 2014.

    Research output: Contribution to conference › Paper

11. Published

    Dignity in Care Homes.

    Windle, G., 15 Oct 2009.

    Research output: Contribution to conference › Paper